Celldex Therapeutics diskutieren
Celldex Therapeutics
WKN: A2PEAB / Symbol: CLDX / Name: Celldex / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
?
-0,78 %
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $25.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Barclays PLC from $25.00 to $21.00. They now have an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by analysts at Barclays PLC from $21.00 to $24.00. They now have an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Ratings data for CLDX provided by MarketBeat
Neueste Beiträge
DA_Davidson in Trade Desk Inc diskutieren